52.35% -0.3848

Avenue Therapeutics Inc (ATXI)

Überblick Nachrichten Preisverlauf Financials Warum fällt ATXI? Forum Prognose Aktiensplit

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31
Periodenlänge	3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic

RVMD

$97.87

16.66%

INCY

$102.51

0.60%

GMAB

$33.60

0.83%

BNTX

$117.42

1.16%

INSM

$159.01

1.86%

ONC

$337.77

0.37%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters